Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shuntTransjugular intrahepatic portosystemic shunt in patients with sinusoidal obstruction syndrome, etiology matters

被引:0
|
作者
Marta Magaz
Juan Carlos García-Pagán
机构
[1] University of Barcelona,Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital ClínicInstitut de Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS)
[2] CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas Y Digestivas),undefined
[3] Health Care Provider of the European Reference Network On Rare Liver Disorders (ERN-Liver),undefined
来源
Hepatology International | 2021年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:568 / 570
页数:2
相关论文
共 50 条
  • [31] Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Recurrent Variceal Hemorrhage
    Popovic, Peter
    Zore, Andrej
    Surlan Popovic, Katarina
    Garbajs, Manca
    Skok, Pavel
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 2013
  • [32] Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter
    Wang, Xiaoze
    Luo, Xuefeng
    Yang, Li
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4568 - 4569
  • [33] Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter
    Xiaoze Wang
    Xuefeng Luo
    Li Yang
    [J]. Digestive Diseases and Sciences, 2021, 66 : 4568 - 4569
  • [34] Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients
    Gou, Xiaoyuan
    Jia, Wenyuan
    He, Chuangye
    Yuan, Xulong
    Niu, Jing
    Xu, Jiao
    Han, Na
    Zhu, Ying
    Wang, Wenlan
    Tie, Jun
    [J]. EUROPEAN RADIOLOGY, 2023, 33 (05) : 3407 - 3415
  • [35] Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients
    Yin, Xiaochun
    Zhang, Feng
    Xiao, Jiangqiang
    Wang, Yi
    He, Qibin
    Zhu, Hao
    Leng, Xiafei
    Zou, Xiaoping
    Zhang, Ming
    Zhuge, Yuzheng
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1264 - 1269
  • [36] Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients
    Charilaou, Paris
    Devani, Kalpit
    Petrosyan, Romela
    Reddy, Chakradhar
    Pyrsopoulos, Nikolaos
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (11) : 3378 - 3388
  • [37] Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome in 51 Chinese patients
    Qi, Xingshun
    Han, Guohong
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 693 - 693
  • [38] Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients
    Xiaoyuan Gou
    Wenyuan Jia
    Chuangye He
    Xulong Yuan
    Jing Niu
    Jiao Xu
    Na Han
    Ying Zhu
    Wenlan Wang
    Jun Tie
    [J]. European Radiology, 2023, 33 : 3407 - 3415
  • [39] Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients
    Paris Charilaou
    Kalpit Devani
    Romela Petrosyan
    Chakradhar Reddy
    Nikolaos Pyrsopoulos
    [J]. Digestive Diseases and Sciences, 2020, 65 : 3378 - 3388
  • [40] Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis:: Clinical, laboratory, psychometric, and electroencephalographic investigations
    Nolte, W
    Wiltfang, J
    Schindler, C
    Münke, H
    Unterberg, K
    Zumhasch, U
    Figulla, HR
    Werner, G
    Hartmann, H
    Ramadori, G
    [J]. HEPATOLOGY, 1998, 28 (05) : 1215 - 1225